167 related articles for article (PubMed ID: 18407589)
21. Down-regulation of X-linked inhibitor of apoptosis synergistically enhanced peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition in colon cancer.
Qiao L; Dai Y; Gu Q; Chan KW; Zou B; Ma J; Wang J; Lan HY; Wong BC
Mol Cancer Ther; 2008 Jul; 7(7):2203-11. PubMed ID: 18645029
[TBL] [Abstract][Full Text] [Related]
22. Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARgamma ligand, troglitazone, on colon cancer cells.
Hosokawa M; Kudo M; Maeda H; Kohno H; Tanaka T; Miyashita K
Biochim Biophys Acta; 2004 Nov; 1675(1-3):113-9. PubMed ID: 15535974
[TBL] [Abstract][Full Text] [Related]
23. A Ligand for peroxisome proliferator-activated receptor gamma inhibits human cholangiocarcinoma cell growth: potential molecular targeting strategy for cholangioma.
Kobuke T; Tazuma S; Hyogo H; Chayama K
Dig Dis Sci; 2006 Sep; 51(9):1650-7. PubMed ID: 16927143
[TBL] [Abstract][Full Text] [Related]
24. PPAR gamma ligand troglitazone lowers cholesterol synthesis in HepG2 and Caco-2 cells via a reduced concentration of nuclear SREBP-2.
Klopotek A; Hirche F; Eder K
Exp Biol Med (Maywood); 2006 Sep; 231(8):1365-72. PubMed ID: 16946405
[TBL] [Abstract][Full Text] [Related]
25. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T
Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitination of p53 is involved in troglitazone induced apoptosis in cervical cancer cells.
Chen HM; Zhang DG; Wu JX; Pei DS; Zheng JN
Asian Pac J Cancer Prev; 2014; 15(5):2313-8. PubMed ID: 24716976
[TBL] [Abstract][Full Text] [Related]
27. PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity.
Takashima T; Fujiwara Y; Higuchi K; Arakawa T; Yano Y; Hasuma T; Otani S
Int J Oncol; 2001 Sep; 19(3):465-71. PubMed ID: 11494023
[TBL] [Abstract][Full Text] [Related]
28. Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB.
Ruan H; Pownall HJ; Lodish HF
J Biol Chem; 2003 Jul; 278(30):28181-92. PubMed ID: 12732648
[TBL] [Abstract][Full Text] [Related]
29. PPAR gamma ligand-induced apoptosis through a p53-dependent mechanism in human gastric cancer cells.
Nagamine M; Okumura T; Tanno S; Sawamukai M; Motomura W; Takahashi N; Kohgo Y
Cancer Sci; 2003 Apr; 94(4):338-43. PubMed ID: 12824901
[TBL] [Abstract][Full Text] [Related]
30. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG
J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072
[TBL] [Abstract][Full Text] [Related]
31. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
[TBL] [Abstract][Full Text] [Related]
32. Growth inhibition of esophageal squamous carcinoma cells by peroxisome proliferator-activated receptor-gamma ligands.
Rumi MA; Sato H; Ishihara S; Ortega C; Kadowaki Y; Kinoshita Y
J Lab Clin Med; 2002 Jul; 140(1):17-26. PubMed ID: 12080324
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
[TBL] [Abstract][Full Text] [Related]
34. Troglitazone upregulates PTEN expression and induces the apoptosis of pulmonary artery smooth muscle cells under hypoxic conditions.
Pi WF; Guo XJ; Su LP; Xu WG
Int J Mol Med; 2013 Nov; 32(5):1101-9. PubMed ID: 24026200
[TBL] [Abstract][Full Text] [Related]
35. Unique ability of troglitazone to up-regulate peroxisome proliferator-activated receptor-gamma expression in hepatocytes.
Davies GF; McFie PJ; Khandelwal RL; Roesler WJ
J Pharmacol Exp Ther; 2002 Jan; 300(1):72-7. PubMed ID: 11752099
[TBL] [Abstract][Full Text] [Related]
36. [Peroxisome proliferator-activated receptor activator troglitazone inhibits angiotensin II-stimulated secretion of vasoactive factors by endothelial cells].
Li YQ; Niu XL; Wang CX; Wei J; Wang SJ; Zhou J
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1030-3. PubMed ID: 17666345
[TBL] [Abstract][Full Text] [Related]
37. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.
Wang M; Wise SC; Leff T; Su TZ
Diabetes; 1999 Feb; 48(2):254-60. PubMed ID: 10334298
[TBL] [Abstract][Full Text] [Related]
38. Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists.
Inoue K; Kawahito Y; Tsubouchi Y; Kohno M; Yoshimura R; Yoshikawa T; Sano H
Biochem Biophys Res Commun; 2001 Sep; 287(3):727-32. PubMed ID: 11563856
[TBL] [Abstract][Full Text] [Related]
39. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.
Baek SJ; Kim JS; Nixon JB; DiAugustine RP; Eling TE
J Biol Chem; 2004 Feb; 279(8):6883-92. PubMed ID: 14662774
[TBL] [Abstract][Full Text] [Related]
40. Troglitazone induces G1 arrest by p27(Kip1) induction that is mediated by inhibition of proteasome in human gastric cancer cells.
Takeuchi S; Okumura T; Motomura W; Nagamine M; Takahashi N; Kohgo Y
Jpn J Cancer Res; 2002 Jul; 93(7):774-82. PubMed ID: 12149143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]